Sino Biopharmaceutical
1177.HK
#2044
Rank
NZ$12.69 B
Marketcap
$0.70
Share price
1.82%
Change (1 day)
8.77%
Change (1 year)
Sino Biopharmaceutical is a company based on Hong Kong that does R&D, production and sales of pharmaceuticals.

Market capitalization of Sino Biopharmaceutical (1177.HK)

Market cap: NZ$12.69 Billion

As of September 2024 Sino Biopharmaceutical has a market cap of NZ$12.69 Billion. This makes Sino Biopharmaceutical the world's 2044th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sino Biopharmaceutical from 2004 to 2024

End of year Market Cap

Year Market cap Change
2024NZ$12.69 B-3.93%
2023NZ$13.21 B-24.47%
2022NZ$17.49 B-9.18%
2021NZ$19.26 B-24.58%
2020NZ$25.53 B-2.21%
2019NZ$26.11 B110.97%
2018NZ$12.37 B-33.14%
2017NZ$18.51 B145.71%
2016NZ$7.53 B-23.71%
2015NZ$9.87 B73.04%
2014NZ$5.70 B19.61%
2013NZ$4.77 B65.85%
2012NZ$2.87 B52.9%
2011NZ$1.88 B-21.46%
2010NZ$2.39 B18.35%
2009NZ$2.02 B280.77%
2008NZ$0.53 B-2.33%
2007NZ$0.54 B43.12%
2006NZ$0.38 B-44.01%
2005NZ$0.67 B55.94%
2004NZ$0.43 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Sino Biopharmaceutical was reported to be:

NZ$12.69 Billion
by Yahoo Finance info icon info icon
NZ$12.69 Billion
by CompaniesMarketCap info icon info icon